For example, in the treatment of head and neck squamous cell carcinoma (HNSCC), Cetuximab, which targets the Epidermal Growth Factor Receptor (EGFR), has been shown to enhance the effects of platinum-based chemotherapy. Here, EGFR is linked to head and neck squamous cell carcinoma.